799 related articles for article (PubMed ID: 15456464)
61. Incidence of colorectal cancer in a population-based cohort of patients with Barrett's oesophagus.
Murphy SJ; Anderson LA; Mainie I; Fitzpatrick DA; Johnston BT; Watson RG; Gavin AT; Murray LJ
Scand J Gastroenterol; 2005 Dec; 40(12):1449-53. PubMed ID: 16316894
[TBL] [Abstract][Full Text] [Related]
62. A surveillance programme for Barrett's oesophagus in a UK general hospital.
Olithselvan A; Gorard DA; McIntyre AS
Eur J Gastroenterol Hepatol; 2007 Apr; 19(4):305-9. PubMed ID: 17353694
[TBL] [Abstract][Full Text] [Related]
63. Acetic acid-enhanced magnification endoscopy in the diagnosis of specialized intestinal metaplasia, dysplasia and early cancer in Barrett's oesophagus.
Fortun PJ; Anagnostopoulos GK; Kaye P; James M; Foley S; Samuel S; Shonde A; Badreldin R; Campbell E; Hawkey CJ; Ragunath K
Aliment Pharmacol Ther; 2006 Mar; 23(6):735-42. PubMed ID: 16556175
[TBL] [Abstract][Full Text] [Related]
64. Barrett's metaplasia as a paradigm for understanding the development of cancer.
Burke ZD; Tosh D
Curr Opin Genet Dev; 2012 Oct; 22(5):494-9. PubMed ID: 22981230
[TBL] [Abstract][Full Text] [Related]
65. Barrett's esophagus: the long and the short of it.
Nandurkar S; Talley NJ
Am J Gastroenterol; 1999 Jan; 94(1):30-40. PubMed ID: 9934728
[TBL] [Abstract][Full Text] [Related]
66. Barrett's esophagus: prevalence and its relationship with dyspeptic symptoms.
Toruner M; Soykan I; Ensari A; Kuzu I; Yurdaydin C; Ozden A
J Gastroenterol Hepatol; 2004 May; 19(5):535-40. PubMed ID: 15086597
[TBL] [Abstract][Full Text] [Related]
67. Prevalence of intestinal metaplasia in the distal esophagus in patients endoscopically suspected for short Barrett's esophagus.
Grassi A; Giannarelli D; Iacopini F; Paoluzi P; Iannetti A; Giovannelli L; Efrati C; Barberani F; Giovannone M; Tosoni M
J Exp Clin Cancer Res; 2006 Sep; 25(3):297-302. PubMed ID: 17167967
[TBL] [Abstract][Full Text] [Related]
68. Endoscopic surveillance in Barrett's esophagus.
Lunedei V; Bazzoli F; Pozzato P; De Luca L; Zagari RM; Fossi S; Ricciardiello L; Maltoni S; Roda E
Minerva Gastroenterol Dietol; 2002 Jun; 48(2):63-71. PubMed ID: 16489297
[TBL] [Abstract][Full Text] [Related]
69. The prevalence of Barrett's oesophagus in a cohort of 1040 Canadian primary care patients with uninvestigated dyspepsia undergoing prompt endoscopy.
Veldhuyzen van Zanten SJ; Thomson AB; Barkun AN; Armstrong D; Chiba N; White RJ; Escobedo S; Sinclair P
Aliment Pharmacol Ther; 2006 Mar; 23(5):595-9. PubMed ID: 16480398
[TBL] [Abstract][Full Text] [Related]
70. [Carcinoma of the oesophagogastric junction and Barrett's esophagus: an almost clear oncologic model?].
Stein HJ; von Rahden BH; Höfler H; Siewert JR
Chirurg; 2003 Aug; 74(8):703-8. PubMed ID: 12928790
[TBL] [Abstract][Full Text] [Related]
71. Relationship between gastro-oesophageal reflux pattern and severity of mucosal damage.
Bredenoord AJ; Hemmink GJ; Smout AJ
Neurogastroenterol Motil; 2009 Aug; 21(8):807-12. PubMed ID: 19374635
[TBL] [Abstract][Full Text] [Related]
72. Distribution of laminins in the basement membranes of the upper gastrointestinal tract and Barrett's oesophagus.
Dave U; Thursz MR; Ebrahim HY; Burke MM; Townsend ER; Walker MM
J Pathol; 2004 Mar; 202(3):299-304. PubMed ID: 14991894
[TBL] [Abstract][Full Text] [Related]
73. Risk of Barrett's oesophagus, oesophageal adenocarcinoma and reflux oesophagitis and the use of nitrates and asthma medications.
Ladanchuk TC; Johnston BT; Murray LJ; Anderson LA;
Scand J Gastroenterol; 2010 Dec; 45(12):1397-403. PubMed ID: 20626305
[TBL] [Abstract][Full Text] [Related]
74. Systematic review with meta-analysis: risk factors for Barrett's oesophagus in individuals with gastro-oesophageal reflux symptoms.
Eusebi LH; Telese A; Cirota GG; Haidry R; Zagari RM; Bazzoli F; Ford AC
Aliment Pharmacol Ther; 2021 May; 53(9):968-976. PubMed ID: 33705573
[TBL] [Abstract][Full Text] [Related]
75. Histological assessment of oesophageal columnar mucosa.
Flejou JF
Best Pract Res Clin Gastroenterol; 2008; 22(4):671-86. PubMed ID: 18656824
[TBL] [Abstract][Full Text] [Related]
76. CagA in Barrett's oesophagus in Colombia, a country with a high prevalence of gastric cancer.
Kudo M; Gutierrez O; El-Zimaity HM; Cardona H; Nurgalieva ZZ; Wu J; Graham DY
J Clin Pathol; 2005 Mar; 58(3):259-62. PubMed ID: 15735156
[TBL] [Abstract][Full Text] [Related]
77. Magnification chromoendoscopy for the detection of intestinal metaplasia and dysplasia in Barrett's oesophagus.
Sharma P; Weston AP; Topalovski M; Cherian R; Bhattacharyya A; Sampliner RE
Gut; 2003 Jan; 52(1):24-7. PubMed ID: 12477754
[TBL] [Abstract][Full Text] [Related]
78. Length of Barrett's oesophagus and cancer risk: implications from a large sample of patients with early oesophageal adenocarcinoma.
Pohl H; Pech O; Arash H; Stolte M; Manner H; May A; Kraywinkel K; Sonnenberg A; Ell C
Gut; 2016 Feb; 65(2):196-201. PubMed ID: 26113177
[TBL] [Abstract][Full Text] [Related]
79. Molecular evaluation of ablative therapy of Barrett's oesophagus.
Hage M; Siersema PD; Vissers KJ; Steyerberg EW; Haringsma J; Kuipers EJ; van Dekken H
J Pathol; 2005 Jan; 205(1):57-64. PubMed ID: 15586364
[TBL] [Abstract][Full Text] [Related]
80. Review: Barrett's oesophagus in Taiwan.
Chen PH
J Gastroenterol Hepatol; 1997 Jun; 12(6):S19-22. PubMed ID: 9195407
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
